A bandage includes a backing sheet portion including a first oligodynamic treatment including a first relatively higher oligodynamic concentration. The bandage further includes an absorbent pad portion provided on a bottom surface of the backing sheet portion. The absorbent pad portion includes a second oligodynamic treatment including a second relatively lower oligodynamic concentration. The second relatively lower oligodynamic concentration is lower than the first relatively higher oligodynamic concentration. The second oligodynamic treatment is operable to release oligodynamic ions directly to the wound site. The first oligodynamic treatment enables the backing sheet portion to provide a reservoir of oligodynamic particles that may propagate outwardly from the bandage over time.

A computer-implemented method and system for tracking skin concerns. Color-coded substrates come in different colors, each color being associate with a different skin concern. The color-coded substrates include at least one hydrocolloid and active agent. The color-coded substrates can come in different area-specific shapes for applying on different areas of the skin or face. The color-coded substrates can come in different dosages. A computing device, such as a smartphone, can be used to take scans of the skin with or without substrates, and the computing device is configured to analyze the skin and color-coded substrates based on color or shape or other symbols to make recommendations so that a subject will be able to track the progress of any skin concern.

A bandage-type apparatus includes a skin condition compartment that is adhered to cover a skin condition with leak-proof adhesive surrounding the compartment that attaches to skin adjacent the skin condition and with a non-adhesive material of the compartment covering the skin condition. A liquid pouch or container with a releasable liquid is coupled to the skin condition compartment and configured for the liquid, such as saline solution, to be released into the compartment to provide a bath or soak in the leak-proof, body-adhered skin condition compartment to provide treatment or relief to the skin condition, such as a sore nipple of a breastfeeding mother.

Systems and methods for a smart bandage for monitoring and treating wounds are provided herein. The smart bandage may be a smart, wearable, flexible multi-layer substrate that may include a system that can monitor wound characteristics, perform autonomous bioanalysis of wound characteristics to determine wound treatment plans in a non-invasive method, perform drug delivery or antimicrobial agent release to treat and prevent infections, and promote healing by electrical stimulation. The smart bandage may be equipped with a wireless network that can communicate with users, such as patients and medical providers, directly about a patient's wound condition and provide for on-demand wound treatment.

The present invention pertains to an integrated wound dressing device for treatment of an insertion site of percutaneous and drug delivery devices. The integrated wound dressing device preferably comprises a transparent film layer having a bottom side, a top side and a perimeter. The bottom side is coated with an adhesive impregnated with an antimicrobial agent. The transparent film has a radius cutout between a central opening and the perimeter. A liquid crystal temperature sensitive film with an adhesive placed on the top side of the transparent film layer is preferably near and around the central opening. The dressing also has a layer of double folded release paper below the bottom side of the transparent film layer. The preferred TLCs used are cholesteryl esters with a preferable temperature detection range of 35-40° C. The preferred antimicrobial agent is chlorohexidine gluconate (CHG).

Disclosed are apparatuses comprising at least one electrode element having a skin-facing surface; a skin contact layer comprising an adhesive composite, and an adhesive tape or bandage. Disclosed are methods comprising positioning one or more electrode assemblies on a target site of a subject, the one or more electrode assemblies comprising at least one electrode element having a skin-facing surface; a skin contact layer comprising a conductive adhesive composite, and an adhesive tape or bandage, wherein the at least one electrode element is electrically coupled to the skin contact layer. In some aspects, the methods further comprise removing at least one of the one or more electrode assemblies from the target site of the subject after a period of time. In some aspects, after removal of the one or more electrode assemblies, the target site is evaluated for an adverse event.

The present invention relates to a smart wound management system and to a method of medical treatment and management for wounds.

In some embodiments, a system includes an applicator pad, an application device (e.g., a grip), and a reservoir. The grip can be releasably couplable to the applicator pad and configured to dispose the applicator pad against a wound of a subject such that pressure can be transferred to the wound via the applicator pad to enhance hemostasis. The reservoir can be configured to contain medication to be released to the wound via the applicator pad.

The present invention relates to an improved wound dressing member, characterized in that the improved wound dressing member is a laminate comprising: a main body having an opening formed in the central portion thereof, wherein the opening is operable and closable by means of a cover; a cover sheet laminated on top of the main body; a release paper laminated below the main body; and the cover sheet capable of opening or closing the opening by being form-fitted into the opening.

A system that transdermally delivers a drug to a patent can be used to reduce suffering from acute/chronical musculoskeletal pain. The system includes a backing layer, an adhesive layer, a topical applicator, a suitable quantity of drug, and a quantity of topical carrier. The topical applicator is connected across and against the backing layer by the adhesive layer. The suitable quantity of drug and the quantity of topical carrier are homogenously mixed together as a topical medication, which is retained and dispensed from the topical applicator. The topical applicator includes a flat applicator body, a plurality of blunted spikes, and a containment rim. The flat applicator body is the structural base of the topical applicator. The containment rim is used to perimetrically confine the topical medication. The blunted spikes are used to increase the surface area of the topical applicator in order to improve its retention of the topical medication.